Registration for a live webinar on 'Phasing Out Animal Testing: A New Era for Pharmaceutical Innovation' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
Topics Covered
- Parkinson's disease
- Amyotrophic lateral sclerosis
- Biological markers
- Primary lateral sclerosis
- MicroRNAs
- Extracellular vesicles
- Diagnosis
Biography
Dr. Sandra Anne Banack is a Senior Scientist at Brain Chemistry Labs in Jackson, Wyoming. She received her Ph.D. degree in Integrative Biology from the University of California, Berkeley in 1996.
She has been a professor at California State University Fullerton Department of Biological Science beginning in 1997 and during this time received faculty recognition for Outstanding Scholarship (2004, 2007), Outstanding Teaching (2005), and Outstanding Contributions to Student Learning (2002). In addition, she was honored with the 2006 College of Natural Science and Mathematics Dean’s Research Award. She has held positions as the Senior Scientist for the Institute of Ethnomedicine since 2004, a Research Associate for the National Tropical Botanical Garden from 2002–2004, and a Research Fellow with Umeå University, Sweden in 1996. She also served in the Department of Botany as a Visiting Assistant Professor at Brigham Young University from 1994 to 1997. Her research extends to biomarkers, exosomes, and diagnostic tools, revolutionizing our understanding of brain health.
Dr. Paul Alan Cox is an ethnobotanist whose scientific research focuses on the ecology of island plants and the uses of plants by island peoples. After receiving his BS in botany from Brigham Young University, he was awarded a Fulbright Fellowship to read for his MS in ecology at the University of Wales at Bangor. He received a Danforth Fellowship and a National Science Foundation Graduate Fellowship for his PhD studies at Harvard University in biology. He subsequently was awarded a Miller Research Fellowship at the Miller Institute for Basic Research in Science at the University of California, Berkeley and later became a University of Melbourne Research Fellow in Australia. Although trained in evolutionary ecology, Cox became increasingly focused on ethnomedicine after his mother died from breast cancer.
He served for years as professor and dean at Brigham Young University and later became the first King Carl XVI Gustaf Professor of Environmental Science at the Swedish Agricultural University and the University of Uppsala, a visiting professorship established by the Royal Academy of Sciences, for an academic year. For seven years he was Director of the Congressionally Chartered National Tropical Botanical Garden in Hawaii and Florida and is currently Executive Director of the Institute for Ethnomedicine in Jackson Hole, Wyoming. He is the author of over 180 scientific papers and reviews, and was chosen by TIME as one of eleven “Heroes of Medicine” for his search for new medicines from plants. In 1997 he received the Goldman Environmental Prize for the conservation efforts described in his book Nafanua: Saving the Samoan Rainforest, which has been translated into German, Japanese, and Samoan. He speaks a variety of island languages and is internationally renowned for his advocacy of indigenous peoples. He served an LDS mission in Samoa.
Rachael Dunlop BSc (Hons, first class) PhD is a senior researcher at Brain Chemistry Labs in Jackson, Wyoming.
She completed her undergraduate and Honours degrees at Adelaide University and her PhD at Sydney University Medical School, Australia.
Her team’s discovery of L-serine as a neuroprotective therapy in neurodegenerative diseases led to clinical trials for ALS, mild cognitive impairment, and Alzheimer’s disease. Rachael’s current work is focused on developing a blood-based diagnostic test to diagnose ALS.
Links
Series:
Categories:
Therapeutic Areas:
External Links
Talk Citation
Banack, S., Cox, P.A. and Dunlop, R. (2025, March 31). MicroRNA as a biomarker for early detection of amyotrophic lateral sclerosis [Audio file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 2, 2025, from https://doi.org/10.69645/NMZF9387.Export Citation (RIS)
Publication History
- Published on March 31, 2025
Financial Disclosures
- Dr. Sandra Banack has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
- Dr. Paul Alan Cox has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
- Dr. Rachael Dunlop has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
MicroRNA as a biomarker for early detection of amyotrophic lateral sclerosis
